- Home
- CLSD vs GRRR Comparison
CLSD vs GRRR Comparison
Compare CLSD & GRRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- GRRR
- Stock Information
- Founded
- CLSD 2011
- GRRR 2001
- Country
- CLSD United States
- GRRR United Kingdom
- Employees
- CLSD N/A
- GRRR N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- GRRR Computer Software: Prepackaged Software
- Sector
- CLSD Health Care
- GRRR Technology
- Exchange
- CLSD Nasdaq
- GRRR Nasdaq
- Market Cap
- CLSD 76.6M
- GRRR 85.6M
- IPO Year
- CLSD 2016
- GRRR N/A
- Fundamental
- Price
- CLSD $1.01
- GRRR $12.18
- Analyst Decision
- CLSD Strong Buy
- GRRR Buy
- Analyst Count
- CLSD 6
- GRRR 1
- Target Price
- CLSD $5.33
- GRRR $13.00
- AVG Volume (30 Days)
- CLSD 230.0K
- GRRR 2.1M
- Earning Date
- CLSD 11-12-2024
- GRRR 12-27-2024
- Dividend Yield
- CLSD N/A
- GRRR N/A
- EPS Growth
- CLSD N/A
- GRRR N/A
- EPS
- CLSD N/A
- GRRR 2.28
- Revenue
- CLSD $7,703,000.00
- GRRR $78,940,347.00
- Revenue This Year
- CLSD N/A
- GRRR $12.29
- Revenue Next Year
- CLSD $91.87
- GRRR $21.40
- P/E Ratio
- CLSD N/A
- GRRR $4.50
- Revenue Growth
- CLSD 248.39
- GRRR 424.97
- 52 Week Low
- CLSD $0.92
- GRRR $2.09
- 52 Week High
- CLSD $2.12
- GRRR $13.00
- Technical
- Relative Strength Index (RSI)
- CLSD 42.14
- GRRR 83.99
- Support Level
- CLSD $0.99
- GRRR $5.75
- Resistance Level
- CLSD $1.05
- GRRR $8.24
- Average True Range (ATR)
- CLSD 0.05
- GRRR 1.05
- MACD
- CLSD 0.00
- GRRR 0.44
- Stochastic Oscillator
- CLSD 15.38
- GRRR 95.89
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About GRRR Gorilla Technology Group Inc. Ordinary shares
Gorilla Technology Group Inc is primarily engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.